| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/10/2013 | US8530181 Method of screening for compounds which affect the cleavage of EphA7 byγ-secretase |
| 09/10/2013 | US8530180 Method for identifying smoker or ex-smoker at risk of chronic obstructive pulmonary disease |
| 09/10/2013 | US8530179 Electrochemical methods of detecting cancer with 4-aminophenyl phosphate |
| 09/10/2013 | US8530178 Hydrolase detection system with caged substrates |
| 09/10/2013 | US8530174 SOGA polynucleotides and polypeptides and uses thereof |
| 09/10/2013 | US8530173 Methods for treatment of cardiovascular disease |
| 09/10/2013 | US8530167 Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering |
| 09/10/2013 | US8530166 Multiplex amplification reaction method for determination of Campylobacter jejuni Penner/capsule type |
| 09/10/2013 | US8530165 Nucleic acid detection method for determining if one or more analyte nucleotides are present in a nucleic acid |
| 09/10/2013 | US8530164 Method for sequencing using branching fraction of incorporatable nucleotides |
| 09/10/2013 | US8530163 Probe, probe set, probe carrier, and testing method |
| 09/10/2013 | US8530162 Method for selectively quantifying VEGF isoforms in a biological sample and uses thereof |
| 09/10/2013 | US8530161 Detection and treatment of polycystic kidney disease |
| 09/10/2013 | US8530160 G-protein coupled receptor kinase-5 polymorphism |
| 09/10/2013 | US8530159 MiR-29-based methods for the diagnosis and prognosis of acute myeloid leukemia (AML) |
| 09/10/2013 | US8530158 System and method for processing a biological sample |
| 09/10/2013 | US8530157 SNP-dependent end labeling method |
| 09/10/2013 | US8530156 Chemically cleavable phosphoramidite linkers for sequencing by ligation |
| 09/10/2013 | US8530155 Methods for diagnosis of common acute lymphoblastic leukemia by determining the level of gene expression |
| 09/10/2013 | US8530154 System and method for nucleic acid sequencing by polymerase synthesis |
| 09/10/2013 | US8530153 Lentiviral transduced dendritic cells for RNAi |
| 09/10/2013 | US8530152 Methods of reducing non-specific interaction in metal nanoparticle assays |
| 09/10/2013 | US8530151 Immobilizing tissue sampling on radiation transparent support; detection human cytomegalo virus; epitope conditioning; contacting with antibodies |
| 09/10/2013 | US8530150 Detection of risk of pre-eclampsia |
| 09/10/2013 | US8529910 Enterococcus antigens |
| 09/10/2013 | US8529906 Compositions for inducing immune responses |
| 09/10/2013 | US8529841 Method for managing treatment of a particular health condition via a phone device |
| 09/10/2013 | US8529840 Method for collecting patient health condition management data at a central server system |
| 09/10/2013 | US8529839 Method for managing treatment of a particular health condition that includes graphing accumulated data |
| 09/10/2013 | US8529838 Method for managing treatment of a patient health condition with a PDA based system |
| 09/10/2013 | US8529835 Biopolymer sensor and method of manufacturing the same |
| 09/10/2013 | CA2737963C Automated diagnostic analyzer and method |
| 09/10/2013 | CA2666448C Method and kit for the detection of live microorganism cells in a sample |
| 09/10/2013 | CA2639414C Membrane concentration assay with nucleic acid cleavage for measuring a component of whole blood |
| 09/10/2013 | CA2605015C Compositions and assays to detect influenza virus a and b nucleic acids |
| 09/10/2013 | CA2603367C Test media and quantitative or qualitative method for identification and differentiation of biological materials in a test sample |
| 09/10/2013 | CA2548308C Phosphatase inhibitor sample collection system |
| 09/10/2013 | CA2544483C Soluble tcr fusion molecules and methods of use |
| 09/10/2013 | CA2532973C Ion channel assay methods |
| 09/10/2013 | CA2529027C D-amino acid peptides |
| 09/10/2013 | CA2513398C Antisense oligonucleotides that inhibit expression of hif-1 |
| 09/10/2013 | CA2492498C Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 09/10/2013 | CA2455399C Propionibacteria strain and method of feeding to ruminant |
| 09/10/2013 | CA2331926C Methods for generating highly diverse libraries |
| 09/10/2013 | CA2281887C Nucleic acid sequences for atp-binding cassette transporter |
| 09/08/2013 | CA2770773A1 Novel method for analyzing circulating tumor cells of a patient for the presence of metastasis-initiating cells |
| 09/06/2013 | WO2013131087A2 Methods and compositions for determining virus susceptibility to non-nucleoside reverse transcriptase inhibitors |
| 09/06/2013 | WO2013131083A1 METHOD FOR USING PROBE BASED PCR DETECTION TO MEASURE THE LEVELS OF CIRCULATING DEMETHYLATED β CELL DERIVED DNA AS A MEASURE OF β CELL LOSS IN DIABETES |
| 09/06/2013 | WO2013131074A1 Methods and reagents for evaluating autoimmune disease and determining antibody repertoire |
| 09/06/2013 | WO2013131044A1 Compositions and methods for detecting allogeneic matter in a subject |
| 09/06/2013 | WO2013131000A1 Emt-inducing transcription factors cooperate with sox9 |
| 09/06/2013 | WO2013130953A2 Autism-associated biomarkers and uses thereof |
| 09/06/2013 | WO2013130910A1 Sample preparation, processing and analysis systems |
| 09/06/2013 | WO2013130880A1 Hypermethylated gene markers for head and neck cancer |
| 09/06/2013 | WO2013130875A1 Rapid antibiotic susceptibility testing |
| 09/06/2013 | WO2013130869A1 Gene expression signatures in cancer |
| 09/06/2013 | WO2013130857A1 Defining diagnostic and therapeutic targets of conserved fetal dna in maternal circulating blood |
| 09/06/2013 | WO2013130848A1 Informatics enhanced analysis of fetal samples subject to maternal contamination |
| 09/06/2013 | WO2013130824A1 Methods and compositions for treating huntington's disease |
| 09/06/2013 | WO2013130797A1 Methods and materials for assessing cyp2d6 genotypes |
| 09/06/2013 | WO2013130791A1 Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer |
| 09/06/2013 | WO2013130773A2 Compositions of microbiota and methods related thereto |
| 09/06/2013 | WO2013130759A1 Formulations and process for isolating viable microorganism from positive blood cultures |
| 09/06/2013 | WO2013130748A1 Prostate cancer markers and uses thereof |
| 09/06/2013 | WO2013130674A1 Compositions and kits for molecular counting |
| 09/06/2013 | WO2013130635A2 Sensor circuit for controlling, detecting, and measuring a molecular complex |
| 09/06/2013 | WO2013130634A1 Tbl1xr1 and tp63 translocations |
| 09/06/2013 | WO2013130613A1 Ectoparasite detection |
| 09/06/2013 | WO2013130604A1 High-throughput method for sialic acid quantitation |
| 09/06/2013 | WO2013130591A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 09/06/2013 | WO2013130521A1 Methods and kits for detecting and diagnosing neurotrauma |
| 09/06/2013 | WO2013130517A1 Dna hypermethylation of promoters of target genes and clinical diagnosis and treatment of hpv related disease |
| 09/06/2013 | WO2013130512A2 Methods and uses for molecular tags |
| 09/06/2013 | WO2013130482A1 Systems and methods for identifyng protein stabilizers |
| 09/06/2013 | WO2013130465A2 Gene expression markers for prediction of efficacy of platinum-based chemotherapy drugs |
| 09/06/2013 | WO2013130417A1 Estrogen metabolite levels and cyp1b1 polymorphisms in lung cancer diagnosis, prognosis, and risk assessment |
| 09/06/2013 | WO2013130364A1 Cancer patient selection for administration of wnt signaling inhibitors using rnf43 mutation status |
| 09/06/2013 | WO2013130347A1 Methods for predicting anti-cancer response |
| 09/06/2013 | WO2013130161A1 Methods of responding to a biothreat |
| 09/06/2013 | WO2013130093A1 Biomarkers for treatment with anti-tubulin chemotherapeutic compounds |
| 09/06/2013 | WO2013130046A2 Extended cascade plasma gun |
| 09/06/2013 | WO2013130029A1 Detection of subject biomarker diagnostic assay for dengue fever and the differentiation of dengue hemorrhagic fever |
| 09/06/2013 | WO2013129906A1 Real-time viral detection method and kit for infectious hypodermaland haematopoietic necrosis virus |
| 09/06/2013 | WO2013129727A1 Analysis method for determining fetal gender and apparatus therefor |
| 09/06/2013 | WO2013128405A1 Real time pcr detection of respiratory syncytial virus |
| 09/06/2013 | WO2013128404A1 Multiplex real-time pcr detection of influenza viruses 2009 h1n1, influenza a and influenza b |
| 09/06/2013 | WO2013128399A1 REAL-TIME PCR DETECTION OF SEASONAL INFLUENZA H1, H3 and B SUBTYPES |
| 09/06/2013 | WO2013128397A1 Real-time pcr detection of streptococcus pyogenes |
| 09/06/2013 | WO2013128281A1 Method for attaching a counter sequence to a nucleic acid sample |
| 09/06/2013 | WO2013128204A1 Method of identifying vdj recombination products |
| 09/06/2013 | WO2013128199A1 A method of molecular typing |
| 09/06/2013 | WO2013128182A1 Polymeric poly (vinyl - diamino - triazine) nanoparticles for use in biosensors |
| 09/06/2013 | WO2013128026A1 Test strip with stacked unidirectional contact pads and inert carrier substrate |
| 09/06/2013 | WO2013128021A1 Test strip with stacked unidirectional contact |
| 09/06/2013 | WO2013128003A1 N-terminally modified oligopeptides and uses thereof |
| 09/06/2013 | WO2013127997A1 Means and methods for the determination of (d)-2-hydroxyglutarate (d2hg) or (d)-2-hydroxyadipic acid |
| 09/06/2013 | WO2013127709A1 Membrane filter including bile acid and a method of manufacturing the same |
| 09/06/2013 | WO2013126993A1 Screening assays for identifying and validating agents that target cancer stem cells |
| 09/06/2013 | WO2013096903A8 Methods for prediction of clinical response to radiation therapy in cancer patients |
| 09/06/2013 | WO2013093635A3 Plasma micrornas for the detection of early colorectal cancer |